SAN DIEGO, Nov. 14, 2011 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that it will host an Investor and Analyst Day at NASDAQ Tower in New York on Monday, November 14, 2011 from 2:00 to 5:00 pm ET. Key members of the company's management team will offer an in-depth discussion of the business, specifically focusing on the recent commercial launch of the MaterniT21 laboratory developed test (LDT).
Space for the event is limited and, therefore, by invitation only. For those who cannot attend, the presentation will be web cast live through the "Investor Relations" section of the Sequenom website at www.sequenom.com. An audio replay will be available for 30 days following the initial presentation web cast.
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at http://www.sequenom.com to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.
|SOURCE Sequenom, Inc.|
Copyright©2010 PR Newswire.
All rights reserved